MedTrace Logo

ImmuneRACE - Immune Response Action to COVID-19 Events

NCT04494893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 808

Last updated 2022-02-16

No results posted yet for this study

Summary

ImmuneRACE is a study, which is designed to better understand the immune response to COVID-19. This is critically important because the immune system may be able to tell us important information about how our own bodies detect and respond to the disease that current tests cannot. De-identified data collected from this study may accelerate the development of better diagnostics for COVID-19 and improve outcomes for many.

Conditions

  • Covid19

Sponsors & Collaborators

  • Covance

    collaborator INDUSTRY

  • Adaptive Biotechnologies

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-24
Primary Completion
2021-03-23
Completion
2021-04-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04494893 on ClinicalTrials.gov